ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 71 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,908 | -41.5% | 27,541 | -33.7% | 0.00% | – |
| Q2 2023 | $95,498 | -25.4% | 41,521 | -1.7% | 0.00% | – |
| Q1 2023 | $127,987 | +19.0% | 42,240 | -8.5% | 0.00% | – |
| Q4 2022 | $107,562 | +32.8% | 46,164 | +8.3% | 0.00% | – |
| Q3 2022 | $81,000 | -35.2% | 42,626 | -7.7% | 0.00% | – |
| Q2 2022 | $125,000 | +8.7% | 46,180 | +19.3% | 0.00% | – |
| Q1 2022 | $115,000 | -32.4% | 38,705 | -11.2% | 0.00% | – |
| Q4 2021 | $170,000 | -6.1% | 43,591 | +3.4% | 0.00% | – |
| Q3 2021 | $181,000 | -44.8% | 42,163 | -61.0% | 0.00% | – |
| Q2 2021 | $328,000 | +67.3% | 108,093 | +97.6% | 0.00% | – |
| Q1 2019 | $196,000 | -16.9% | 54,700 | -11.2% | 0.00% | -100.0% |
| Q4 2018 | $236,000 | -54.1% | 61,624 | +13.3% | 0.00% | 0.0% |
| Q3 2018 | $514,000 | +30.5% | 54,394 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $394,000 | – | 54,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |